PGIM Jennison Health Sciences Fund - Class A (PHLAX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
39.16
-0.40 (-1.01%)
At close: Jul 8, 2026

PHLAX Holdings Information

PHLAX is a mutual fund with a total of 55 individual holdings. The top holdings are Eli Lilly and Company stock at 17.35%, Merck & Co. at 6.06%, UnitedHealth Group at 5.87%, Thermo Fisher Scientific at 4.56%, and argenx SE at 3.56%.

Total Holdings
55
Top 10 Percentage
52.67%
Asset Class
Equity
Fund Category
Health
Assets
1.49B
Forward PE Ratio
20.10

Breakdown by Asset Class

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company17.35%218,000
2MRKMerck & Co., Inc.6.06%708,913
3UNHUnitedHealth Group Incorporated5.87%214,171
4TMOThermo Fisher Scientific Inc.4.56%128,459
5ARGXargenx SE3.56%59,035
6VRTXVertex Pharmaceuticals Incorporated3.37%104,411
7DHRDanaher Corporation3.28%249,533
8ISRGIntuitive Surgical, Inc.3.08%100,530
9SWX: LONNLonza Group AG3.02%65,672
10CVSCVS Health Corporation2.52%384,647
11n/aPrudential Govt Money Mkt Fd2.50%34,655,221
12INSMInsmed Incorporated2.28%296,139
13ROIVRoivant Sciences Ltd.2.21%1,022,182
14SYKStryker Corporation2.16%98,162
15SIONSionna Therapeutics, Inc.2.01%651,048
16ONCBeOne Medicines AG1.82%87,672
17PCVXVaxcyte, Inc.1.78%479,492
18ALGNAlign Technology, Inc.1.75%138,932
19AAgilent Technologies, Inc.1.73%177,040
20PVLAPalvella Therapeutics, Inc.1.56%183,037
21APGEApogee Therapeutics, Inc.1.42%240,387
22CABACabaletta Bio, Inc.1.35%4,960,717
23NAMSNewAmsterdam Pharma Company N.V.1.30%534,102
24DNTHDianthus Therapeutics, Inc.1.28%190,688
25KYMRKymera Therapeutics, Inc.1.26%215,651
Showing 25 of 55 holdings
Subscribe to see the full list
As of May 31, 2026